Mitral Regurgitation 2008 David M. Leder, MD 8/20/08.

Slides:



Advertisements
Similar presentations
PREOPERATIVE ECHOCARDIOGRAPHIC CLUES FOR THE REPAIR OF TRICUSPID VALVE AND ASSESSMENT OF RIGHT VENTRICULAR FUNCTIONS Dr.Gökhan Kahveci.
Advertisements

Mitral Regurgitation Francesca N. Delling, MD July 8, 2009.
3D Echocardiography. u 3D Transesophageal echocardiography has become practical for intraoperative use u Technology provides 3D visualization of MV and.
Non-Invasive Echo Assessment of Valvular Regurgitation Part 1 MR
Echocardiographic Assessment of LV Systolic Function
Mitral valve. Repair vs. Replacement >%80 of MR are repairable Produces more physiological flow states It better preserves LV function Less thrombolic.
MITRAL REGURGITATION. 2D ASSESSMENT LOOK CAREFULLY AT THE MITRAL VALVE APPARATUS.
Mitral Apparatus Mitral Valve leaflets Chordae tendinae Papillary muscles MV annulus LV myocardium and LA wall adjacent to the Papillary muscles.
Percutaneous mitral valve repair using the MitraClip® device (e-valve)
ECHOCARDIOGRAM (ECHO) FOR MITRIAL REGURGITATION
Mitral valve repair Prof Alain Carpentier is considered the modern day father of MV repair. His publication in the 1980’s called the French correction.
Minimally invasive mitral and tricuspid valve surgery Prof. Parwis Massoudy Klinikum Passau, Germany Clinic for Cardiac Surgery Head of Department.
Aortic Regurgitation Mohammed AL Ghamdi.
Ischemic MR Guidelines
Diastolic Dysfunction as Diagnosed and Quantified by Echocardiography LAM-1965AO (07/13) For Broker/Dealer Use Only.
Ventricular Diastolic Filling and Function
Pathology of Valvular Diseases
Valvular Heart Disease
Mitral Valve Anatomy-important Anatomic Relationship The functional components of the mitral valve apparatus include: Annulus Leaflets Chordae Papillary.
Mitral Valve Disease Prof JD Marx UFS January 2006.
Impact of Concomitant Tricuspid Annuloplasty on Tricuspid Regurgitation Right Ventricular Function and Pulmonary Artery Hypertension After Degenerative.
TOPIC 1 Group A. The heart pumps blood throughout the entire body The heart beats approximately 72 beats per minute supplying cells of the body with nutrients.
Congenital Mitral Valve Disease
Valve Surgery V.Rohn. Valve Surgery History before the era of ECC 1925 – Suttar – first successful digital commisurolysis of mitral valve 1952 – Hufnagel.
Mitral Regurgitation. Abnormalities of the Mitral Valve Valve Leaflets Chordae Tendineae Papillary Muscles Mitral Annulus.
Adult Cardiac Valve Disease Marvin D. Peyton, M.D. Thoracic and Cardiovascular Surgery University of Oklahoma Health Sciences Center.
MITRAL RECONSTRUCTIVE SURGERY DEPARTMENT OF CARDIOTHORACIC SURGERY HOSPITAL DE SANTA MARIA LISBOA PORTUGAL.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Imaging the Left Atrial Appendage Prior to, During,
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Pregnancy in Patients With Pre-Existing Cardiomyopathies.
MitraClip Mitral Valve Repair System Abbott Vascular MitraClip Mitral Valve Repair System Abbott Vascular Alexandra Camesas & Nathan Kukowski Biomaterials.
Date of download: 6/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Emerging Role of Exercise Testing and Stress.
Date of download: 7/7/2016 Copyright © The American College of Cardiology. All rights reserved. From: Toward clinical risk assessment inhypertrophic cardiomyopathy.
Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Echocardiography for Percutaneous Heart Pumps J.
Primary Mitral Regurgitation Degenerative Mitral Valve Disease
Role of Device Therapy in FMR: Challenges and Opportunities
Terminology Functional MR Ischemic MR Associated MR Organic MR
3D Echo and Secondary MR Also referred to as Functional, Ischemic, Carpentier Type IIIb Dr. Bollen Dr. Shernan.
Mitral Regurgitation: Epidemiology, Pathophysiology and When to Repair
Cardiothoracic Surgery
Mitral Valve Surgery For Heart Failure
Structural and Functional Mitral Regurgitation:
Benjamin B. Peeler, MD, Irving L. Kron, MD 
Ischemic Mitral Regurgitation: Chordal-Sparing Mitral Valve Replacement  Tirone E. David, MD  Operative Techniques in Thoracic and Cardiovascular Surgery 
Volume 108(10 suppl 1):II-111-II-115
Tricuspid valve disease
2015 The American Association for Thoracic Surgery Consensus Guidelines: Ischemic mitral valve regurgitation  Irving L. Kron, MD, Michael A. Acker, MD,
Feasibility and Intermediate Term Outcome of Repair of Prolapsing Anterior Mitral Leaflets With Artificial Chordal Replacement in 152 Patients  Gerald.
Ischemic Mitral Regurgitation
Pacopexy: Restoration Procedure for Nonischemic Dilated Cardiomyopathy
Ischemic Mitral Regurgitation: Chordal-Sparing Mitral Valve Replacement  Tirone E. David, MD  Operative Techniques in Thoracic and Cardiovascular Surgery 
SAM.
Figure 3 3D printing of aortic and mitral valves
Norman H Silverman, MD, Doff B McElhinney, MD 
Zoll Firm Lecture Series
Ανεπάρκεια Μιτροειδούς : Σταυρόλεξο για δυνατούς λύτες Ποσοτικοποίηση με Ηχωκαρδιογράφημα και ο ρόλος των δοκιμασιών φόρτισης Μαρία Μπόνου Διευθύντρια,
Mitral valve replacement after late failure of mitral valve repair
Repair Techniques for Ischemic Mitral Regurgitation
Posterior Leaflet Augmentation in Ischemic Mitral Regurgitation Increases Leaflet Coaptation and Mobility  Arminder S. Jassar, MBBS, Masahito Minakawa,
Functional mitral stenosis after surgical annuloplasty for ischemic mitral regurgitation: Importance of subvalvular tethering in the mechanism and dynamic.
Benjamin B. Peeler, MD, Irving L. Kron, MD 
Beyond Extended Myectomy for Hypertrophic Cardiomyopathy: The Resection- Plication-Release (RPR) Repair  Sandhya K. Balaram, MD, PhD, Mark V. Sherrid,
Percutaneous Balloon Valvuloplasty
Joseph A. Dearani, MD, Sameh M. Said, MD, Harold M
Predicting recurrent mitral regurgitation after mitral valve repair: A difficult endeavor and a necessity  Denis Bouchard, MD, Louis P. Perrault, MD,
Quick but effective surgery for functional mitral regurgitation secondary to aortic valve disease  Masashi Komeda, MD, PhD  The Journal of Thoracic and.
Intermediate-term results of a nonresectional dynamic repair technique in 662 patients with mitral valve prolapse and mitral regurgitation  Gerald M.
Barlow disease: Simple and complex
Mitral valve hemodynamics after repair of acute posterior leaflet prolapse: Quadrangular resection versus triangular resection versus neochordoplasty 
Repair of congenital tricuspid valve abnormalities with artificial chordae tendineae  V.Mohan Reddy, MD, Doff B McElhinney, MD, Michael M Brook, MD, Norman.
Presentation transcript:

Mitral Regurgitation 2008 David M. Leder, MD 8/20/08

Outline Anatomy Etiology of mitral regurgitation Management strategies for chronic severe MR Quantification of MR severity on echocardiography Advances in mitral valve repair

Anatomy Functionally includes: Left ventricular myocardium Subvalvular apparatus (papillary muscles and chordae tendinea) Mitral annulus Mitral valve leaflets Left atrium

Anatomy:

Etiology of Mitral Regurgitation: Primary: -Myxomatous -Endocarditis -Rheumatic -Trauma -Anorexic drugs Functional (Secondary): -LV systolic dysfunction -Ischemic heart disease -Hypertrophic CM

Functional (Carpentier) Classification: Type I = normal leaflet motion but with annular dilatation or leaflet perforation Type II = leaflet prolapse (eg myxomatous disease) or papillary muscle rupture Type III = restricted leaflet motion. IIIa = rheumatic disease IIIb = ischemic or idiopathic cardiomyopathy.

Bonow, R. O. et al. J Am Coll Cardiol 2006;48:598-675 Management strategy for patients with chronic severe mitral regurgitation Bonow, R. O. et al. J Am Coll Cardiol 2006;48:598-675 Copyright ©2006 American College of Cardiology Foundation. Restrictions may apply.

Management – Symptomatic patients:

Management – Asymptomatic patients: >90%

How to measure severity of mitral regurgitation:

I. Hemodynamic Determinants of MR RgV = Regurgitant volume. ROA = Regurgitant oriface area. Cd = Discharge coefficient MPG = Mean systolic pressure gradient b/t the LV and LA T = Duration of MR during systole.

Regurgitant Oriface Area (ROA) Typically fixed in rheumatic MR b/c the valve is fibrotic, calcified, and immobile. In DCM and myxomatous disease, it is often dynamic and load dependent. ROA is a fundamental determinant of MR severity and therefore its measurement/calculation is critical.

Discharge coefficient (Cd) Is a constant. Accounts for contraction of the flow stream as it passes through the anatomic orifice. It is dependent upon orifice geometry, flow, and fluid viscosity. Is not affect by clinical variations in loading conditions.

Mean systolic pressure gradient (MPG) Is a primary determinant of MR severity, but its effect on echo variables is mitigated by 2 factors: 1. Hemodynamic changes tend to move LV and LA pressures in the same direction, thus the net effect is blunted. 2. It is a function of its square root. eg. a 144mmHg gradient compared to a 100mmHg gradient only results in a 20% difference in the calculated MR volume. (ie. 12 v. 10)

Duration of MR during systole (T) Particularly important in myxomatous degeneration, where late systolic MR may lead to overestimation of MR severity by techniques that rely on single frame measurements (eg PISA or vena contracta).

II. Mitral Valve Anatomy Includes the leaflets, annulus, chordae, papillary muscles, and left ventricle. Severe MR seldom occurs when the mitral valve and left ventricle are anatomically normal. LA size and LV function provide clues to the severity and chronicity of MR.

III. Doppler Color Flow Mapping Represents an image of the spatial distribution of velocities within the imaging plane. It can be profoundly affected by instrument settings and hemodynamic variables. Since spatial distribution of velocities is not a primary determinant of MR severity according to the Gorlin equation, some argue it should not be heavily relied upon to grade MR severity. That being said, it does offer several potential ways to assess MR severity.

Color Flow Jet Area Generally, larger jets which extend deep into the LA represent more MR than small thin jets. However, the correlation b/t jet area and MR severity is poor due to technical and hemodynamic limitations. Therefore avoid grading MR severity by “eyeballing” the color flow jet area. Exception: a small central jet w/ an area <4.0cm2 or <10% of LA area, is almost always mild MR.

Vena Contracta Width Represents the smallest, highest velocity region of a flow jet and is typically located at or just downstream from the regurgitant orifice. Should be measured in a plane perpendicular to mitral leaflet closure (eg PLA). If the regurgitant orifice is circular, then vena contracta width should be an excellent marker of the ROA. However, the regurgitant orifice in MR is often elongated along the coaptation line…ie, like a smiley face.

Vena Contracta Width Long-axis Short-axis

Vena Contracta Width Has been shown to be accurate in assessing the severity of MR. According to ASE: <0.3cm = mild MR >/=0.7cm = severe MR A strength of this method is that it works equally well for central and eccentric jets.

Proximal Isovelocity Surface Area (PISA) Based on the hydrodynamic principle that the flow profile of blood approaching a circular orifice forms concentric, hemispheric shells of increasing velocity and decreasing surface area. In MR, color flow mapping is usually able to image one of these hemispheres that corresponds to the aliasing velocity of the instrument. The aliasing velocity should be adjusted to identify a flow convergence region with a hemispheric shape. The radius of this hemisphere is then measured and flow rate is calculated as the product of the surface area of the hemisphere and the aliasing velocity.

Proximal Isovelocity Surface Area (PISA)

Proximal Isovelocity Surface Area (PISA) Assuming that the maximal PISA radius occurs at the time of peak regurgitant velocity, the maximal EROA can be derived as: PkVreg = the peak velocity of the regurgitant jet by continuous wave Doppler. Generally, an EROA >/=0.4cm2 is considered to be severe MR. <0.2cm2 is mild MR

Proximal Isovelocity Surface Area (PISA) EROA = [6.28 x (.8)(.8) ml/s] / [480 cm/s] = 0.3cm2

Limitations of PISA It is more accurate for central jets. In MR, the orifice shape is often elliptical rather circular/hemispheric. Any error is determining the location/radius of the orifice is squared. Therefore PISA is more accurate if the aliasing velocity can be adjusted to obtain a radius of >/=1cm. For determination of EROA, it is essential that the CW signal by well aligned with the regurgitant jet.

IV: Quantitative Doppler Volumetric Measurements: In the absence of regurgitation, stroke volume should be equal at different sites, eg the mitral and aortic annulus. In the presence of regurgitation (assuming the absence of an intracardiac shunt), the flow through the affected valve is larger than through other competent valves.

Quantitative Doppler Volumetric Measurements:

Quantitative Doppler Volumetric Measurements: Common errors: 1. Failure to measure the valve annulus properly. 2. Failure to trace the modal velocity of the pulsed Doppler tracing. 3. Failure to position the sample volume correctly, at the level of the annulus.

V. Adjunctive Findings Continuous wave Doppler Pulsed Doppler -the density of the CW signal is a useful qualitative index of MR severity (a dense signal suggests worse MR) -an unusually low maximum velocity may indicate hemodynamic compromise (high LA and low LV systolic pressures) Pulsed Doppler -patients with severe MR usually exhibit dominant early filling (E>1.2m/s); an A-wave dominant inflow pattern virtually excludes severe MR. Pulmonary vein flow -with increasing severity of MR, systolic velocity in the pulmonary veins progressively decreases and reverses in severe MR.

Summary

Summary

Evolving Concepts and Technologies in Mitral Valve Repair

Key Concept: the fibrous skeleton of the heart is fixed and its length does not change with mitral valve disease.

Valvular-Ventricular Interactions The collagenous matrix elements within the chordae tendineae and papillary muscles are histologically continuous with the collagen network of the heart at one end and the mitral valve annulus and leaflets at the other end. Removal of the papillary muscles and chordae results in ventricular dilatation, increased wall stress and afterload, and decreased contractile fxn. Late survival after MVR can be enhanced with the use of chordal-sparing techniques.

Annuloplasty Rings The annulus is a dynamic, saddle-shaped structure. The original Carpentier ring was flat and rigid. Newer mitral rings have attempted to replicate this normal saddle shape and flexibility.

Annuloplasty Rings Despite a more “normal” valve physiology, superior long-term clinical results with flexible rings have not been demonstrated. The most recent annuloplasty rings are cause-specific, geometrically shaped to accommodate the underlying pathology and not to replicate the “normal” mitral annulus.

Commercially Available Rings and Band

Novel (Percutaneous) Approaches to Mitral Valve Repair

Coronary Sinus Approaches Concept: Place a device in the coronary sinus to push against the posterior portion of the mitral annulus and ideally improve coaptation of the posterior and anterior mitral valve leaflets Anatomic limitations: Often the coronary sinus does not lie directly adjacent to the posterior mitral valve annulus. The CS is an atrial structure and not in the same plane as the mitral valve annulus The left circumflex artery may lie in between The distance between the CS and posterior mitral annulus increase with chronic ischemic MR

Coronary Sinus Approaches

Annular Approaches Include annular shrinking via magnets or heating. The Mitralign device approaches the posterior annulus directly from the LV and positions stitches to allow annular cinching. The PS3 system approaches the posterior annulus from the atrial septum and tethers a device from the P2 vicinity toward the atrial septum.

Alfieri Revisted: Edge-to-edge surgical concept modified for a percutaneous approach. Feasibility study completed in the US and a randomized phase 2 trial is ongoing. Surgical experience with the technique demonstrated significant recurrent MR if it was not accompanied by an annuloplasty Reoperation at 5 years = 30% v. 8%, p=0.02

Subvalvular Approaches Developed to treat complex ischemic mitral valve disease: 1. Approximate the papillary muscles (papillary muscle sling) 2. Pull the papillary muscles toward the annulus to release leaflets tethering. 3. Cut secondary chords to reduce tethering of the leaflets. All have been used with some success but the need is uncommon, as the majority of patients with MR undergoing coronary bypass are treated with simple annuloplasty rings.

Coapsys and i-Coapsys Evolved from the concept of moving the ventricle, rather than the annulus, to increase leaflet coaptation and eliminate functional MR. Can be placed off pump w/ echo guidance or via a minimally invasive approach w/ fluoro guidance. Employs a transventricular splint

Coapsys and i-Coapsys The pads are tightened gently to pull the ventricle into the region of the papillary muscles and also to move the posterior leaflet to better coapt with the anterior leaflet.

The End: Questions?